Rotundine b

CAS No. 483-14-7

Rotundine b( L-Tetrahydropalmatine | (-)-Tetrahydropalmatine | Caseanine | Gindarine )

Catalog No. M19458 CAS No. 483-14-7

Rotundine (L-tetrahydropalmatine L-THP) is a selective dopamine D1 receptor antagonist with IC50 of 166 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 47 Get Quote
100MG 68 Get Quote
500MG 165 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Rotundine b
  • Note
    Research use only, not for human use.
  • Brief Description
    Rotundine (L-tetrahydropalmatine L-THP) is a selective dopamine D1 receptor antagonist with IC50 of 166 nM.
  • Description
    Rotundine (L-tetrahydropalmatine L-THP) is a selective dopamine D1 receptor antagonist with IC50 of 166 nM.(In Vivo):It is reported that Rotundine (l-THP) possesses a blocking effect on dopamine D1 and D2 receptors and can inhibit physical dependence in morphine dependent mice and significantly reduce the development of the conditional place preference induced by morphine in mice. On day 1 and 7, there is no difference in locomotor counts between the Rotundine groups (6.25, 12.5, and 18.75 mg/kg) and saline group [F(3, 37)=1.360, P>0.05, F(3, 37)=0.348, P>0.05, respectively]. Locomotor counts are greatly increased in the oxycodone group compare with the saline group. Rotundine at doses of 6.25, 12.5, and 18.75 mg/kg antagonizes hyperactivity induced by oxycodone [F(4, 60)=15.76, P<0.01]. Rotundine (6.25, 12.5 mg/kg) does not affect the magnitude of sensitization, but there is a marked difference between oxycodone+oxycodone group and Rotundine (18.75 mg/kg)+oxycodone+oxycodone group, indicating that Rotundine (18.75 mg/kg) greatly inhibits the development of oxycodone sensitization [F(4, 62)=8.766, P<0.01].
  • In Vitro
    ——
  • In Vivo
    It is reported that Rotundine (l-THP) possesses a blocking effect on dopamine D1 and D2 receptors and can inhibit physical dependence in morphine dependent mice and significantly reduce the development of the conditional place preference induced by morphine in mice. On day 1 and 7, there is no difference in locomotor counts between the Rotundine groups (6.25, 12.5, and 18.75 mg/kg) and saline group [F(3, 37)=1.360, P>0.05, F(3, 37)=0.348, P>0.05, respectively]. Locomotor counts are greatly increased in the oxycodone group compare with the saline group. Rotundine at doses of 6.25, 12.5, and 18.75 mg/kg antagonizes hyperactivity induced by oxycodone [F(4, 60)=15.76, P<0.01]. Rotundine (6.25, 12.5 mg/kg) does not affect the magnitude of sensitization, but there is a marked difference between oxycodone+oxycodone group and Rotundine (18.75 mg/kg)+oxycodone+oxycodone group, indicating that Rotundine (18.75 mg/kg) greatly inhibits the development of oxycodone sensitization [F(4, 62)=8.766, P<0.01].
  • Synonyms
    L-Tetrahydropalmatine | (-)-Tetrahydropalmatine | Caseanine | Gindarine
  • Pathway
    GPCR/G Protein
  • Target
    Dopamine Receptor
  • Recptor
    D1 receptor 5-HT1A D2 receptor D3 receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    483-14-7
  • Formula Weight
    355.43
  • Molecular Formula
    C21H25NO4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:8 mg/mL (22.5 mM);Ethanol:<1 mg/mL;Water:<1 mg/mL
  • SMILES
    [H][C@@]12CC3=CC=C(OC)C(OC)=C3CN1CCC1=C2C=C(OC)C(OC)=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Wang JB et al. Future Med Chem 2012 4(2) 177-186.
molnova catalog
related products
  • Tavapadon

    Tavapadon (PF 6649751, PF-06649751) is an orally available dopamine D1 receptor partial agonist for treatment of Parkinson's disease.

  • Tiapride hydrochlori...

    Tiapride is a drug that selectively blocks D2 and D3 dopamine receptors in the brain.

  • Rotigotine

    A non-selective agonist of the dopamine D3 receptor (Ki=0.71 nM); has 10-fold selectivity for the D3 receptor over the D2, D4, and D5 receptors and 100-fold selectivity for the D3 receptor over the D1 receptor.